Back to Search
Normal

DERMAL LABORATORIES (IRELAND) LIMITED

#680034 Private limited by shares

Company Details

Company Number 680034
Company Type Private limited by shares
Type Code 1119
Status Normal

Important Dates

Registration Date 21 October 2020
Last Annual Return 28 February 2026
Last Accounts Filed 31 May 2025

Industry Classification (NACE)

NACE Code: 74.90

Registered Address

38 MAIN STREET

SWORDS,DUBLIN

SWORDS, DUBLIN, IRELAND

K67E0A2

Contact Details

Phone Number Unknown
Email Address Unknown

Company Website

Company Description

Dermal Laboratories (Ireland) Limited is a specialist pharmaceutical company dedicated to the research, development and supply of innovative treatments for a variety of diseases and conditions. Drawing on cutting‑edge science, Dermal creates a comprehensive range of products that are designed to meet the therapeutic needs of patients while supporting the clinical decisions of healthcare professionals.

The company’s portfolio is divided into three clear pillars. First, a catalogue of products that addresses specific medical indications, each backed by rigorous scientific data. Second, detailed information on the diseases and conditions for which these treatments are formulated, helping patients and clinicians understand the benefits and appropriate use. Third, a dedicated resource hub for healthcare professionals, offering product specifications, prescribing guidance and the latest research insights. Dermal’s commitment to transparency is reflected in its user‑friendly website, which provides easy access to product information, disease overviews and contact details for further enquiries.

Based in Ireland, Dermal Laboratories serves a broad audience that includes patients seeking effective therapies, doctors and pharmacists requiring reliable product data, and the wider medical community looking for up‑to‑date treatment options. Their approachable, professional ethos ensures that both consumers and clinicians receive clear, trustworthy information to support better health outcomes.